# Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System

> **NCT03810833** · NA · COMPLETED · sponsor: **MediBeacon** · enrollment: 12 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DEVICE:** Brilliance device sensor

## Key facts

- **NCT ID:** NCT03810833
- **Lead sponsor:** MediBeacon
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-16
- **Primary completion:** 2019-09-23
- **Final completion:** 2019-09-23
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03810833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03810833, "Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03810833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*